IL-10 and IFN-γ gene expression in chronic Chagas disease patients after in vitro stimulation with recombinant antigens of Trypanosoma cruzi

Cytokine

Volumn 58, Issue 2, 2012, Pages 207-212

  de Melo, Adriene Siqueira ^a   de Lorena, Virginia Maria Barros ^a   de Moura Braz, Suellen Carvalho ^a   Docena, Cássia ^a   de Miranda Gomes, Yara ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Biological markers; Chagas disease; Cytokines; Gene expression; Recombinant antigens

Indexed keywords

CYTOPLASMATIC REPETITIVE ANTIGEN; FLAGELLAR REPETITIVE ANTIGEN; INTERLEUKIN 10; MESSENGER RNA; PARASITE ANTIGEN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL STIMULATION; CHAGAS DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE ACTIVATION; GENE EXPRESSION PROFILING; HEART DISEASE; HUMAN; IFN GAMMA GENE; IL 10 GENE; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA ANALYSIS; TRYPANOSOMA CRUZI;

ADULT; ANTIGENS, PROTOZOAN; BASE SEQUENCE; CHAGAS DISEASE; CHRONIC DISEASE; DNA PRIMERS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; MIDDLE AGED; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 84859212194     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.01.008     Document Type: Article

References (47)

1. Coura J.R., Dias J.C.P. Epidemiology, control and surveillance of Chagas disease - 100years after its discovery. Mem Inst Oswaldo Cruz 2009, 104:31-40.
2. Petherick A. Chagas disease. Nature Outlook 2010, 465(7301):S10-S11.
3. Ribeiro A.L.P., Rocha M.O.C. Forma indeterminada da doença de Chagas: considerações acerca do diagnóstico e do prognóstico. Rev Soc Bras Med Trop 1998, 31:301-314.
4. Brasil, Ministério da Saúde, Consenso Brasileiro em doença de Chagas, Rev Soc Bras Med Trop 38 (2005) 29.
5. Gutierrez F.R.S., Guedes P.M.M., Gazzinelli R.T., Silva J.S. The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol 2009, 31:673-685.
6. Dutra W.O., Gollob K.J. Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 2008, 21:287-292.
7. Sathler-Avelar R., Vitelli-Avelar D.M., Teixeira-Carvalho A., Martins-Filho O.A. Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?. Mem Inst Oswaldo Cruz 2009, 104:246-251.
8. Dutra W.O., Menezes C.A.S., Villani F.N.A., Costa G.C., Silveira A.B.M., Reis D.A., et al. Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Mem Inst Oswaldo Cruz 2009, 104:208-218.
9. Dutra W.O., Martins-Filho O.A., Cançado J.R., Pinto-Dias J.C., Brener Z., Gazzinelli G., et al. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol 1996, 43:88-93.
10. - cells from chagasic patients: distinct repertoire and cytokine expression. Clin Exp Immunol 2004, 137:129-138.
11. + lymphocytes. Am J Trop Med Hyg 1993, 48:637-644.
12. Vitelli-Avelar D.M., Sathler-Avelar R., Dias J.C.P., Pascoal V.P.M., Teixeira-Carvalho A., Lage P.S., et al. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3CD16CD56 natural killer T cells and CD4CD25 regulatory T lymphocytes. Scand J Immunol 2005, 62:297-308.
13. Correa-Oliveira R., Gomes J.A.S., Lemos E.M., Cardoso G.M., Reis D.D., Adad S., et al. The role of the immune response on the development of severe clinical forms of human chagasic disease. Mem Inst Oswaldo Cruz 1999, 94:253-255.
14. Cunha-Neto E., Bilate A.M., Hyland K.V., Fonseca S.G., Kalil J., Engman D.M. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 2006, 39:41-54.
15. Gomes J.A.S., Bahia-Oliveira L.M.G., Rocha M.O.C., Martins-Filho O.A., Gazzinelli G., Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human chagas' disease is due to a Th1-specific immune response. Infect Immun 2003, 71:1185-1193.
16. Souza P.E.A., Rocha M.O.C., Rocha-Vieira E., Menezes C.A.S., Chaves A.C.L., Gollob K.J., et al. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbity. Infect Immun 2004, 72:5283-5291.
17. Laucella S.A., Postan M., Martin D., Fralish B.H., Albareda M.C., Alvarez M.G., et al. Frequency of interferon-γ-producing T cells specific for Trypanosma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 2004, 189:909-918.
18. Menezes CAS, Teixeira MM, Dutra WO. A resposta imunológica dos pacientes chagásicos; 2009. Available from: <> [accessed 20 May 2010]. http://www.fiocruz.br/chagas/cgi/cgilua.exe/sys/start.htm?sid=163.
19. Lorca M., Gonzalez A., Veloso C., Reyes V., Vergara U. Immunodetection of antibodies in sera from symptomatic and asymptomatic chilean Chagas' disease patients with Trypanosoma cruzi recombinant antigens. Am J Trop Med Hyg 1992, 46:44-49.
20. Lafaille J.J., Linss J., Krieger M.A., Souto-Padrón T., Wanderley S., Goldenberg S. Structure and expression of two Trypanosoma cruzi genes encoding antigenic proteins bearing repetitive epitopes. Mol Biochem Parasitol 1989, 35:127-136.
21. Krieger M.A. Use of recombinant antigens for the accurate immunodiagnosis of Chagas' disease. Am J Trop Med Hyg 1992, 46:427-434.
22. Verçosa A.F.A., Lorena V.M.B., Carvalho C.L., Melo M.F.A.D., Cavalcanti M.G.A., Silva E.D., et al. Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic chagasic patients. J Clin Lab Anal 2007, 21:271-276.
23. Lorena V.M.B., Verçosa A.F.A., Machado R.C.A., Moitinho-Silva L., Cavalcanti M.G.A., Silva E.D., et al. Cellular immune response from chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi. J Clin Lab Anal 2008, 21:1-8.
24. Vasconcelos R.H.T., Amaral F.N., Cavalcanti M.G.A.M., Silva E.D., Ferreira A.G.P., Morais C.N.L., et al. Increased levels of IgA antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi differentiate digestive forms of Chagas disease. Hum Immunol 2010, 71:964-967.
25. Lorena V.M.B., Lorena I.M.B., Braz S.C.M., Melo A.S., Melo M.F.A.D., Melo M.G.A.C., et al. Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi. Scand J Immunol 2010, 72:529-539.
26. Vasconcelos R.H.T., Azevedo E.A.N., Cavalcanti M.G.A.M., Silva E.D., Ferreirad A.G.P., Morais C.N.L., et al. Immunoglobulin M antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi in chronic chagasic patients. Hum Immunol 2011, 72:402-405.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 5:227-680.
28. Morrissey J.H. Silver stain for proteins in polyacrylamide gel: a modified procedure with enhanced uniform sensitivity. Anal Biochem 1981, 117:307-310.
29. Control of Chagas disease. World Health Organ Tech Rep Ser 2002, 905:109. World Health Organization.
30. Mocellin S., Provenzano M., Rossi C.R., Pilati P., Nitti D., Lise M. Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment. J Immunol Methods 2003, 280:1-11.
31. Wilhelm J., Pingoud A. Real-time polymerase chain reaction. Chembiochem 2003, 4:1120-1128.
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 45:1-29.
33. Vitelli-Avelar D.M., Sathler-Avelar R., Teixeira-Carvalho A., Pinto Dias J.C., Gontijo E.D., Faria A.M., et al. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease. Scand J Immunol 2008, 68:516-525.
34. Bahia-Oliveira L.M.G., Gomes J.A.S., Rocha O.C. IFN-γ in human Chagas' disease: protection or pathology?. Braz J Med Biol Res 1998, 31:127-135.
35. Dutra W.O., Gollob K.J., Pinto-Dias J.C., Gazzinelli G., Correa-Oliveira R., Coffman R.L., et al. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand J Immunol 1997, 45:74-80.
36. Cuna W.R., Encina J.L.R., Cuna C.R. Interferon-γ or IL-10 production is induced by related Trypanosoma cruzi antigens. J Parasitol 2000, 86:295-299.
37. high regulatory T cells in morbidity in Chagas disease. Front Biosci 2007, 12:2797-2806.
38. + T cells in Trypanosoma cruzi infection. Curr Opin Immunol 2009, 21:385-390.
39. + T cells in chronic Chagas' disease patients. Int Immunol 2006, 18:465-471.
40. + T cells to immune senescence. J Immunol 2009, 183:4103-4108.
41. Hall B.S., Pereira M.A. Dual role for transforming growth factor b dependent signaling in Trypanosoma cruzi infection of mammalian cells. Infect Immun 2000, 68:2077-2081.
42. 2-macroglobulin. Infect Immun 2002, 70:5115-5123.
43. Cunha-Neto E., Dzau V.J., Allen P.D., Stamatiou D., Benvenutti L., Higuchi M.L., et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol 2005, 167:305-313.
44. Soares M.B.P., Lima R.S., Rocha L.L., Vasconcelos J.F., Rogatto S.R., Santos R.R., et al. Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. J Infect Dis 2010, 202:416-426.
45. Dutra W.O., Gollob K.J., Pinto-Dias J.C., Gazzinelli G., Correa-Oliveira R., Coffman R.L., et al. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand J Immunol 1997, 45:74-80.
46. Bilate A.M.B., Salemia V.M., Ramiresa F.J., Brito T., Russod M., Fonseca S.G., et al. TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy. Microbes Infect 2007, 9:1104-1113.
47. Manque P.A., Probst C., Pereira M.C.S., Rampazzo R.C.P., Ozaki L.S., Pavoni D.P., et al. Trypanosoma cruzi infection induces a global host cell response in cardiomyocytes. Infect Immun 2011, 79:1855-1862.